Smith & Nephew plc NPW1.F Stock
Smith & Nephew plc Price Chart
Smith & Nephew plc NPW1.F Financial and Trading Overview
Smith & Nephew plc stock price | 11.48 EUR |
Previous Close | 12.78 EUR |
Open | 12.84 EUR |
Bid | 12.95 EUR x 300000 |
Ask | 13.15 EUR x 300000 |
Day's Range | 12.84 - 12.84 EUR |
52 Week Range | 10.21 - 15.18 EUR |
Volume | 1K EUR |
Avg. Volume | 84 EUR |
Market Cap | 11.29B EUR |
Beta (5Y Monthly) | 0.517 |
PE Ratio (TTM) | 55.804348 |
EPS (TTM) | 0.28 EUR |
Forward Dividend & Yield | 0.35 (2.72%) |
Ex-Dividend Date | October 5, 2023 |
1y Target Est | N/A |
NPW1.F Valuation Measures
Enterprise Value | 14.01B EUR |
Trailing P/E | 55.804348 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.1097772 |
Price/Book (mrq) | 2.141308 |
Enterprise Value/Revenue | 2.619 |
Enterprise Value/EBITDA | 12.342 |
Trading Information
Smith & Nephew plc Stock Price History
Beta (5Y Monthly) | 0.517 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 15.18 EUR |
52 Week Low | 10.21 EUR |
50-Day Moving Average | 12.53 EUR |
200-Day Moving Average | 12.67 EUR |
NPW1.F Share Statistics
Avg. Volume (3 month) | 84 EUR |
Avg. Daily Volume (10-Days) | 100 EUR |
Shares Outstanding | 874.32M |
Float | 865.34M |
Short Ratio | N/A |
% Held by Insiders | 0.20% |
% Held by Institutions | 54.96% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.375 |
Trailing Annual Dividend Yield | 2.93% |
5 Year Average Dividend Yield | 219.00% |
Payout Ratio | 1.5 |
Last Split Factor | 9:11 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | July 1, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 4.07% |
Operating Margin (ttm) | 10.05% |
Gross Margin | 70.40% |
EBITDA Margin | 21.21% |
Management Effectiveness
Return on Assets (ttm) | 4.37% |
Return on Equity (ttm) | 4.10% |
Income Statement
Revenue (ttm) | 5.35B EUR |
Revenue Per Share (ttm) | 6.15 EUR |
Quarterly Revenue Growth (yoy) | 5.20% |
Gross Profit (ttm) | N/A |
EBITDA | 1.14B EUR |
Net Income Avi to Common (ttm) | 218M EUR |
Diluted EPS (ttm) | 0.23 |
Quarterly Earnings Growth (yoy) | -2.80% |
Balance Sheet
Total Cash (mrq) | 190M EUR |
Total Cash Per Share (mrq) | 0.22 EUR |
Total Debt (mrq) | 3.04B EUR |
Total Debt/Equity (mrq) | 58.09 EUR |
Current Ratio (mrq) | 2.195 |
Book Value Per Share (mrq) | 5.994 |
Cash Flow Statement
Operating Cash Flow (ttm) | 374M EUR |
Levered Free Cash Flow (ttm) | -625000 EUR |
Profile of Smith & Nephew plc
Country | Germany |
State | N/A |
City | Watford |
Address | Building 5 |
ZIP | WD18 8YE |
Phone | 44 1923 477 100 |
Website | https://www.smith-nephew.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 19000 |
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products, including instruments, technologies, and implants to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Q&A For Smith & Nephew plc Stock
What is a current NPW1.F stock price?
Smith & Nephew plc NPW1.F stock price today per share is 11.48 EUR.
How to purchase Smith & Nephew plc stock?
You can buy NPW1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Smith & Nephew plc?
The stock symbol or ticker of Smith & Nephew plc is NPW1.F.
Which industry does the Smith & Nephew plc company belong to?
The Smith & Nephew plc industry is Medical Devices.
How many shares does Smith & Nephew plc have in circulation?
The max supply of Smith & Nephew plc shares is 874.34M.
What is Smith & Nephew plc Price to Earnings Ratio (PE Ratio)?
Smith & Nephew plc PE Ratio is 40.98214300 now.
What was Smith & Nephew plc earnings per share over the trailing 12 months (TTM)?
Smith & Nephew plc EPS is 0.28 EUR over the trailing 12 months.
Which sector does the Smith & Nephew plc company belong to?
The Smith & Nephew plc sector is Healthcare.